Positive Partial 12-Week Blood Sugar Results from Lexaria’s GLP-1 Diabetes Animal Study
DehydraTECH-liraglutide and select DehydraTECH-CBD formulations were the top performing blood sugar groups KELOWNA, BC / ACCESSWIRE / October 24, 2024...
Brain
BridgeBio Shares Positive Data from High Dose Cohort of Phase 1/2 CANaspire Study of Gene Therapy BBP-812 for Canavan Disease at ESGCT 2024
- Continued, progressive improvement in motor function and achievement of motor milestones at 12-months post-treatment represents an important and statistically...
AlzeCure to Present at the International Partnering Conference Bioscience 2024 on November 7
STOCKHOLM, SE / ACCESSWIRE / October 24, 2024 / AlzeCure Pharma (STO:ALZCUR)(FRA:AC6) AlzeCure Pharma AB (publ) (FN STO: ALZCUR), a...
MEDTEQ+ and AGE-WELL announce 16 envisAGE collaborative projects to enhance older adults’ quality of life with Canadian innovations
EDMONTON, AB, Oct. 23, 2024 /CNW/ - MEDTEQ+ and AGE-WELL proudly announce the first 16 collaborative projects resulting from an unprecedented national...
CNS Pharmaceuticals Announces Pricing of $3 Million Registered Direct Offering of Common Stock Priced At-The-Market Under Nasdaq Rules
HOUSTON, TX / ACCESSWIRE / October 23, 2024 / CNS Pharmaceuticals, Inc. (NASDAQ:CNSP) ("CNS" or the "Company"), a biopharmaceutical company...
Soaak Technologies Selected to Present at the U.S. Air Force “Air Mobility Command” Fall Industry Preview Event on October 30th, 2024
Soaak's Groundbreaking Therapeutic Sound Frequency Compositions to Be Showcased as a Solution to Enhance Operational Wellness within the U.S. Air...
The 136th Canton Fair: BrainCo’s Noninvasive Brain-computer Technology Changes Life for People in Need
GUANGZHOU, China, Oct. 23, 2024 /PRNewswire/ -- At the 136th Canton Fair, BrainCo, a pioneering force in brain-computer technology solutions, returned...
Sabinsa and Postbiotics, Inc. Announce a Multinational Distribution Agreement for the Postbiotic Dietary Supplement Ingredient PoZibio
WINSTON-SALEM, NC / ACCESSWIRE / October 23, 2024 / Postbiotics, Inc. and Sabinsa Corporation, announced today a multinational distribution agreement...
Masimo to Report Third Quarter 2024 Financial Results after Market Close on Tuesday, November 5
Conference call and webcast to begin at 1:30 p.m. PT (4:30 p.m. ET) IRVINE, Calif.--(BUSINESS WIRE)--Masimo (NASDAQ: MASI) will release...
Lin Health to Collaborate with Mayo Clinic to Expand Access to Evidence-Based, Tech-Enabled Chronic Pain Care
Retraining the brain's neural circuitry through a behavioral health approach empowers people living with chronic pain to avoid costly and...
LISA Launches First Diagnostics Crowdfund Projects in Response to FDA Final LDT Rule
Goal to Bring CAP/COLA Labs Together for Innovative FDA-Compliant Assays CARLSBAD, Calif., Oct. 22, 2024 /PRNewswire/ -- The Laboratory Integration Strategic...
Positive Partial 12-Week Body Weight Results from Lexaria’s GLP-1 Diabetes Animal Study
DehydraTECH-liraglutide and select DehydraTECH-CBD formulations were the top performing weight loss groupsAccelerated rates of weight loss were experienced during the...
Taysha Gene Therapies to Present Biodistribution Data from an Analysis Evaluating AAV9 Gene Therapy Delivery at the Upcoming 31st Annual ESGCT Congress
Data from an analysis of five NHP studies showed lumbar IT administration led to widespread and consistent biodistribution of AAV9...
Annovis to Highlight Buntanetap’s Alzheimer’s Research Progress with Presentations at CTAD 2024
MALVERN, Pa., Oct. 22, 2024 (GLOBE NEWSWIRE) -- via IBN – Annovis Bio Inc. (NYSE: ANVS) ("Annovis" or the "Company"),...
ZyVersa Therapeutics Highlights Published Data Demonstrating That Obesity Results in Neuroinflammation Implicated in Development of Neurodegenerative Diseases
Recent evidence links obesity-driven inflammation to diminished brain health and neurodegenerative diseases such as Alzheimer’s and Parkinson’s diseasesThe newly published...
BriaCell Reports Outperforming Metastatic Breast Cancer Patients and Standard-Beating Survival Data
55% of BriaCell patients1 remained alive one year since enrollment in BriaCell’s Phase 2 study, markedly exceeding the survival rate...
Cognition Therapeutics Releases New Episode of “Conversations” Podcast: Executing Clinical Research in Dementia with Lewy Bodies (DLB)
PURCHASE, N.Y., Oct. 22, 2024 (GLOBE NEWSWIRE) -- Cognition Therapeutics, Inc. (the “Company” or “Cognition”) (NASDAQ: CGTX), a clinical-stage company...
NLS Pharmaceutics Secures Key Patent in Japan for Mazindol ER in the Treatment of Heroin Dependence
ZURICH, SWITZERLAND / ACCESSWIRE / October 21, 2024 / NLS Pharmaceutics Ltd. (NASDAQ:NLSP)(NASDAQ:NLSPW) ("NLS" or the "Company"), a Swiss clinical-stage...
Global Health Exhibition Opens its Doors Tomorrow to Record-Breaking 100,000+ Attendees to World’s Premier Healthcare Transformation Event
Kingdom of Saudi Arabia opens the Global Health Exhibition (21-23 October 2024) tomorrow, a major international healthcare event with 100,000+...
Nurix Therapeutics Presents Positive Results from the Ongoing Clinical Trial of Its BTK Degrader NX-5948 in Patients with Relapsed/Refractory Waldenstrom’s Macroglobulinemia
NX-5948 demonstrated robust clinical activity with objective responses observed in 7 of 9 (77.8%) evaluable Waldenstrom’s patients in the ongoing...